Trial Profile
Tau-imaging in tauopathies; Alzheimer's disease and non-AD dementias
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 Oct 2018
Price :
$35
*
At a glance
- Drugs Flortaucipir-F-18 (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Diagnostic use
- Acronyms TITAN
- 16 May 2017 Planned number of patients changed from 140 to 200.
- 30 Nov 2016 New trial record